Stock ALCAR CARMAT
Add to a list
To use this feature you must be a member
Log inSign up

Financials CARMAT

Equities

ALCAR

FR0010907956

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris
Other stock markets
 11:35:14 2024-05-31 am EDT 		5-day change 1st Jan Change
3.15 EUR -.--% Intraday chart for CARMAT +5.00% -52.99%
May. 21 CARMAT : Invest Securities remains Buy, lowers its target CF
May. 17 Oddo BHF Cuts Carmat PT, Affirms Neutral Rating MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 242.7 358.5 312.3 204.2 165.8 108.5 - -
Enterprise Value (EV) 1 203.6 361.4 325.1 208.1 165.8 162.9 208.7 231.6
P/E ratio -5.7 x -9.93 x -5.13 x -4.4 x -3.09 x -2.36 x -3.47 x -10 x
Yield - - - - - - - -
Capitalization / Revenue 347 x - 142 x 681 x 59.2 x 7.31 x 2.9 x 1.22 x
EV / Revenue 291 x - 148 x 694 x 59.2 x 11 x 5.57 x 2.6 x
EV / EBITDA -4.94 x -13.1 x -6.37 x -4.14 x -3.26 x -5.01 x -10.2 x 7.64 x
EV / FCF -4.98 x -6.65 x -5.25 x -3.71 x - -3.01 x -5.28 x -31.7 x
FCF Yield -20.1% -15% -19% -27% - -33.2% -18.9% -3.15%
Price to Book 6.24 x 47.2 x 330 x 14.3 x - -1.55 x -0.86 x -0.77 x
Nbr of stocks (in thousands) 12,590 12,667 15,349 19,581 24,742 34,453 - -
Reference price 2 19.28 28.30 20.35 10.43 6.700 3.150 3.150 3.150
Announcement Date 2/12/20 2/10/21 2/16/22 2/23/23 4/24/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 0.7 - 2.2 0.3 2.8 14.85 37.48 88.9
EBITDA 1 -41.23 -27.58 -51.08 -50.24 -50.82 -32.5 -20.55 30.3
EBIT 1 -42.4 -36.4 -52.4 -51.9 -52.5 -43.53 -32.37 11.66
Operating Margin -6,057.14% - -2,381.82% -17,300% -1,875% -293.13% -86.39% 13.11%
Earnings before Tax (EBT) 1 -44.2 -38.9 -63.74 -55.77 -55.57 -56.31 -46.89 -11.68
Net income 1 -42.6 -37 -61.9 -53.7 -53.9 -39.6 -30.39 -16.48
Net margin -6,085.71% - -2,813.64% -17,900% -1,925% -266.63% -81.09% -18.53%
EPS 2 -3.380 -2.850 -3.970 -2.370 -2.170 -1.337 -0.9067 -0.3150
Free Cash Flow 1 -40.89 -54.37 -61.93 -56.12 - -54.1 -39.5 -7.3
FCF margin -5,841.96% - -2,815.09% -18,707.67% - -364.31% -105.4% -8.21%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 2/12/20 2/10/21 2/16/22 2/23/23 4/24/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2020 S2 2021 S1 2021 Q3 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2 2026 S1
Net sales 1 - - - 1.1 1.1 2.2 0.06 0.06 - - 0.3 0.6 2.244 5.49 12.61 21.92 35.39 56.78
EBITDA - - - - - - - - - - - - - - - - - -
EBIT -20.6 -15.8 -25.5 -13.38 -13.38 -26.9 -12.54 -12.54 -25.1 - -26.8 - -26.62 -26.1 -25.99 -23.54 -18.88 -10.5
Operating Margin - - - -1,216.36% -1,216.36% -1,222.73% -20,900% -20,900% - - -8,933.33% - -1,186.5% -475.41% -206.11% -107.39% -53.35% -18.49%
Earnings before Tax (EBT) -21.61 -17.3 - -18.39 -18.39 -36.71 -13.47 -13.47 -26.9 - - - -27.94 -28.11 -28.21 -25.71 -21.18 -12.79
Net income -20.8 -16.2 -26.4 -17.77 -17.77 -35.5 -13 -13 -26 - - -26.7 -27.2 -24.69 -24.79 -23.79 -19.27 -10.84
Net margin - - - -1,615.45% -1,615.45% -1,613.64% -21,666.67% -21,666.67% - - - -4,450% -1,211.94% -449.73% -196.59% -108.53% -54.45% -19.09%
EPS - - -1.713 -1.140 -1.140 -2.257 - - - - - - - -0.8200 -0.7300 -0.6600 -0.4800 -0.2500
Dividend per Share - - - - - - - - - - - - - - - - - -
Announcement Date 9/9/20 2/10/21 9/15/21 9/15/22 2/16/22 2/16/22 9/15/22 9/15/22 9/15/22 2/23/23 2/23/23 9/25/23 4/24/24 - - - - -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 2.96 12.8 3.9 - 54.4 100 123
Net Cash position 1 39.1 - - - - - - -
Leverage (Debt/EBITDA) - -0.1072 x -0.2506 x -0.0776 x - -1.674 x -4.876 x 4.061 x
Free Cash Flow 1 -40.9 -54.4 -61.9 -56.1 - -54.1 -39.5 -7.3
ROE (net income / shareholders' equity) -143% - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 3.090 0.6000 0.0600 0.7300 - -2.030 -3.670 -4.080
Cash Flow per Share 2 -3.190 -4.010 -3.240 -2.400 - -0.9800 -0.7000 -0.1900
Capex 1 0.65 2.33 1.76 1.75 - 3.23 3.4 4.6
Capex / Sales 92.68% - 80.14% 582.67% - 21.77% 9.07% 5.17%
Announcement Date 2/12/20 2/10/21 2/16/22 2/23/23 4/24/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for CARMAT

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.15 EUR
Average target price
12.32 EUR
Spread / Average Target
+291.27%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

1st Jan change Capi.
CARMAT Stock CARMAT
-52.99% 118M
STRYKER CORPORATION Stock Stryker Corporation
+13.73% 130B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-8.17% 10.99B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
-4.33% 8.35B
GLAUKOS CORPORATION Stock Glaukos Corporation
+41.80% 5.67B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-21.94% 4.72B
AXONICS, INC. Stock Axonics, Inc.
+7.81% 3.42B
ENOVIS CORPORATION Stock Enovis Corporation
-10.26% 2.76B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-10.29% 2.11B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-13.58% 1.92B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. ALCAR Stock
  4. Financials CARMAT